EurekaMag
+ Translate
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine


Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine



Current Opinion in Pediatrics 16(1): 80-84



ISSN/ISBN: 1040-8703

PMID: 14758119

DOI: 10.1097/00008480-200402000-00015

Varicella zoster virus is the cause of both varicella (chickenpox) and herpes zoster (shingles). A live attenuated varicella vaccine was developed in 1974 and was approved in 1995 by the United States Food and Drug Administration for administration to both healthy children (>12 months of age) and adults who are susceptible to varicella. Many studies have shown varicella vaccine to be highly effective. Widespread use of the varicella vaccine in the United States has led to important changes in the epidemiology of the infection. The purpose of this review is to summarize the most recent and important findings regarding the impact that the widespread use of varicella vaccine has had on the epidemiology of varicella zoster infections in children. Data from the United States Centers for Disease Control and Prevention have shown a dramatic decline in the incidence of varicella (76 to 87% from 1995 to 2000), with the greatest decline observed in preschool children, as well as a reduction in the number of hospitalizations for cases of varicella. However, as the proportion of children in the United States who have received the varicella vaccine has increased there have been several recent reports in which the effectiveness of the vaccine was substantially lower than expected. In particular, reports during outbreaks of varicella in children have noted increases in breakthrough disease in children who were vaccinated before the age of 15 months, in children with asthma, in those who received the varicella vaccine soon after the measles, mumps, and rubella vaccine (<28 days), and in children who received the vaccine more than 3 years before the development of disease. Although reports of outbreaks of chickenpox in highly immunized groups have raised questions regarding the need for changes to the current vaccination policy, data undeniably indicate that immunization with varicella vaccine has been and continues to be successful in reducing the burden of disease in children and that universal immunization should continue to be a priority in the United States

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036031024

Download citation: RISBibTeXText

Related references

Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. Journal of Pediatrics 116(2): 184-189, 1990

Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine. Biken Journal 23(3): 135-141, 1980

Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. Journal of Infectious Diseases 171(1): 13-17, 1995

A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella. Pediatric Infectious Disease Journal 28(7): 653-655, 2009

Association between antibody response to live attenuated varicella zoster virus vaccine and subsequent varicella-like illness in Canadian children immunized during the second year of life. Pediatric Research 37(4 Part 2): 110A, 1994

Protective efficacy of live attenuated varicella zoster virus vaccine against naturally acquired varicella zoster infection. Pediatric Research 16(4 Part 2): 148A, 1982

Live attenuated varicella vaccine: Evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. The Journal of Pediatrics 116(2): 184-189, 1990

T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. The Journal of Immunology (1950) 142(2): 636-641, 1989

T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. Journal of Immunology 142(2): 636-641, 1989

Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine. Journal of Infectious Diseases 158(6): 1245-1252, 1988

Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine. Vaccine 20(31-32): 3638-3643, 2002

Expression of interleukin-2 receptor, CD25, on CD4 lymphocytes in response to varicella-zoster virus antigen among patients with malignancies immunized with live attenuated varicella vaccine. Pediatrics International: Official Journal of the Japan Pediatric Society 41(1): 32-36, 1999

The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. New England Journal of Medicine 325(22): 1545-1550, 1991

Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus. Viruses 12(10), 2020

Comparison of varicella zoster virus replication in nonimmunocompromised children with varicella and the recipients of the live vaccine. Abstracts of the Annual Meeting of the American Society for Microbiology 85: 281, 1985